Work

Inactivation of the nuclear receptor TR3 as an important new drug target for treating RCC.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e15618

Authors: Maen Abdelrahim, Stephen Safe, Ala Abudayyeh

Institutions: Baylor College of Medicine, Texas A&M University, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Nuclear Receptors and Signaling

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3000740600

Cites:

Cited by:

Related to: 10